Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Heerspink, HJL; Stefansson, BV; Chertow, GM; Correa-Rotter, R; Greene, T; Hou, FF; Lindberg, M; McMurray, J; Rossing, P; Toto, R; Langkilde, AM; Wheeler, DC

Heerspink, HJL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.; Heerspink, HJL (corresponding author), George Inst, George Inst Global Hlth, Sydney, NSW, Australia.

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020; 35 (2): 274

Abstract

Background Recent cardiovascular outcome trials have shown that sodium-glucose co-transporter 2 (SGLT2) inhibitors slow the progression of chronic kid......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索